Dan Small is a medical anthropologist and lecturer at the University of British Columbia.
Since 2018, British Columbia has been pursuing legal action against pharmaceutical companies for their involvement in the opioid crisis. Within the wider context of North America, there have been over 2600 such lawsuits against the pharmaceutical companies including Purdue, Johnston and Johnson, Teva Pharmaceutical and Endo International. The Purdue pharmaceutical company, the maker of OxyContin, has recently filed for bankruptcy in response to the lawsuits. I believe a suitable strategy for examining the wider variables that have contributed to the opioid crisis: a Royal Commission. This is needed in order to widen public scrutiny beyond the role of pharmaceutical companies to include investigation of the overarching causes of Canada’s overdose epidemic.
Ariane Litalien is a medical student in the Class of 2020 at McGill University
I was about halfway through my second year as a medical student at McGill University when—for a variety of health-related reasons—life decided I needed to take a break from my studies. I packed up my short white coat, Littmann stethoscope, and practice suturing tools in a square box, wrote “transition to clerkship” in tidy Sharpie letters on the top flap, and started looking for a full-time job.
Like Vancouver and a handful of European countries, Montreal’s public health agency (CIUSSS du Centre-Sud-de-l'Île-de-Montréal) was on the verge of opening four supervised injection sites for intravenous drug users across the city. Given my professional experience related to social work and HIV, I decided to apply for a position as an outreach worker. ...continue reading →